What is Wedbush’s Forecast for KNSA Q2 Earnings?
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Wedbush cut their Q2 2025 earnings per share estimates for Kiniksa Pharmaceuticals in a report issued on Tuesday, April 29th. Wedbush analyst D. Nierengarten now expects that the company will post earnings of $0.24 per share for the quarter, down from their prior forecast of $0.38. Wedbush […]
